Sign in

NCT06414109Completed

Mindfulness-Based Intervention for Adolescents With Chronic Migraine

Source: ClinicalTrials.gov · Last updated 4 Jul 2025

Brief summary (registry, in English)

The goal of this study is to assess feasibility and acceptability of a mindfulness-based intervention adapted for adolescents with migraine to inform a future randomized trial assessing effects of the intervention on headache-related outcomes.

Status (registry)
Completed
Study type
Interventional
Enrollment
17 (actual)
First submitted
10 May 2024
Start date
4 Jun 2024
Primary completion date
23 May 2025
Lead sponsor
University of Colorado, Denver
Diseases
Migraine
NCT number
NCT06414109

What you commit to

  • Study type: Interventional
  • Participants enrolled: 17
  • From 4 Jun 2024 to the primary completion date, 23 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Major comorbid medical condition (e.g., cancer, epilepsy)

Other

  • Active psychosis or suicidal ideation
  • Inability to provide consent/assent

Who the study is looking for

  • Age 13 to 18 years
  • Diagnosed with migraine by medical provider using criteria from the International Classification of Headache Disorders, Third Edition
  • Patient report of \>= 8 headache days per month
  • PedMIDAS Score of \> 10 (at least mild headache-related disability)

Age in the registry: 13 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Children's Hospital Colorado
Coordinator of this site? Confirm its status
AuroraUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.